Zynex gains amid report it's pursuing strategic options, including a sale

Oct. 30, 2023 9:45 PM ETZynex, Inc. (ZYXI)By: Joshua Fineman, SA News Editor

TENS, Transcutaneous Electrical Nerve Stimulation in Physical Therapy.

mladenbalinovac/E+ via Getty Images

Zynex (NASDAQ:ZYXI) rose 2% amid a report that the medical device maker is evaluating its options, including a possible sale.

The company is working with Cantor Fitzgerald to review its options, including a takeover, a merger, a divestiture, a recapitalization, or another transaction, according to a Bloomberg report, which cited people familiar.

There’s no certainty that Zynex (ZYXI) will decide to pursue a deal, according to the report. Zynex has a market cap of $283 million.


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Roy Walsh

Related post